Biosimilars pipeline report: A guide for understanding the growing market
By AmerisourceBergen
To date, there have been 61 approvals and 42 launches in the U.S. biosimilars market.
Biosimilars are a promising product category, one that can provide patients and doctors with more affordable treatment options. As this market matures, its pipeline continues to grow. This reference guide is a useful tool to visualize and understand the current product landscape and potential future of this emerging market.
To view and read this report, please fill out the form.
Topics:
Biosimilars
